82 reports of this reaction
1.9% of all ARSENIC TRIOXIDE reports
#5 most reported adverse reaction
PNEUMONIA is the #5 most commonly reported adverse reaction for ARSENIC TRIOXIDE, manufactured by Cephalon, LLC. There are 82 FDA adverse event reports linking ARSENIC TRIOXIDE to PNEUMONIA. This represents approximately 1.9% of all 4,344 adverse event reports for this drug.
Patients taking ARSENIC TRIOXIDE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for ARSENIC TRIOXIDE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for ARSENIC TRIOXIDE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 82 FDA reports for ARSENIC TRIOXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 1.9% of all adverse event reports for ARSENIC TRIOXIDE, making it a notable side effect.
If you experience pneumonia while taking ARSENIC TRIOXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.